Clinical Trial Update: The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combined use of an anti-fibrotic agent with platelet-rich plasma for healing skeletal muscle after acute injuries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Muscle Injury
• Sport-related Muscle Injury

Drugs mentioned

• Anti-fibrotic agent (anti-fibrotic agent)
• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Mostafa Hassanein, Msc | Conditions: PRP, Losartan | Phase 4 | Status: COMPLETED